# Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

> **NCT05635838** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 69 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Ruxolitinib cream
- **DRUG:** Vehicle cream

## Key facts

- **NCT ID:** NCT05635838
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2023-10-19
- **Final completion:** 2024-03-14
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635838, "Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05635838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*